Delhi High Court Orders Fresh Review of Harvard’s Patent on Lab-Engineered Insulin Cells

The Delhi High Court directed a re-examination of Harvard University’s patent application concerning lab-engineered insulin-producing cells, setting aside the earlier rejection by the Patent Controller.

The Court noted that the Controller failed to adequately consider the amended claims submitted during proceedings, instead relying largely on the original claims.

Observing that these revised claims could materially affect the assessment of patentability, the Court held that such oversight warranted fresh scrutiny.

It thus remanded the matter for reconsideration in accordance with law, highlighting the importance of properly evaluating all claim amendments in patent adjudication.

[President & Fellows of Harvard College v. Controller of Patent]